PASG
Passage Bio, Inc. - Common Stock (PASG)
$46
About Passage Bio, Inc. - Common Stock (PASG)
Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Details
Daily high
$3.56
Daily low
$3.39
Price at open
$3.52
52 Week High
$20.00
52 Week Low
$3.29
Market cap
11.3M
Dividend yield
-
Volume
25,908
Avg. volume
16,283
P/E ratio
-.31
Passage Bio, Inc. - Common Stock News
Details
Daily high
$3.56
Daily low
$3.39
Price at open
$3.52
52 Week High
$20.00
52 Week Low
$3.29
Market cap
11.3M
Dividend yield
-
Volume
25,908
Avg. volume
16,283
P/E ratio
-.31